Esperion Therapeutics Inc.

www.esperion.com

USA

3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108

NASDAQ:ESPR

Esperion is a pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C